COMMUNIQUÉS West-GlobeNewswire

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 avril 2018
04/05/2018
Nombre total de droits de vote et d'actions composant le capital social au 30 avril 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France ( [...]
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
04/05/2018
EuroPCR Exhibit will Highlight Package-to-Patient Design Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that the Colibri [...]
ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares
04/05/2018
SINGAPORE, May 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (TPEx:6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]
Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time
04/05/2018
SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference
04/05/2018
NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, Ph [...]
Celsion Corporation to Hold First Quarter 2018 Financial Results Conference Call on Friday, May 11, 2018
04/05/2018
LAWRENCEVILLE, N.J., May 04, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss financial results for the quarter ended March 31, 2018 and [...]
GBT Announces New Employment Inducement Grants
04/05/2018
SOUTH SAN FRANCISCO, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that on May 1, 2018, the compensation committee of the Company’s board of directors [...]
Verona Pharma to Present at Bio€quity Europe 2018
04/05/2018
LONDON, May 04, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Tetra BioPharma Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001
04/05/2018
OTTAWA, May 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V: TBP ) (OTCQB:TBPMF), and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for [...]
Genocea to Host First Quarter 2018 Financial Results Conference Call & Webcast on May 10, 2018 at 9 a.m. ET
04/05/2018
CAMBRIDGE, Mass., May 04, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. ( NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a conference call and [...]
Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9
04/05/2018
EMERYVILLE, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
Capricor Therapeutics to Present First Quarter 2018 Financial Results and Corporate Update on May 10
04/05/2018
LOS ANGELES, May 04, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]
MediWound to Host First Quarter 2018 Financial Results Conference Call on May 10 at 8:30 a.m. Eastern Time
04/05/2018
YAVNE, Israel, May 04, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Lexicon Pharmaceuticals Announces Publication of New XERMELO® (Telotristat Ethyl) Data in Clinical Therapeutics
04/05/2018
Significant Dose-Dependent Effects on Changes in Weight Gain and Biochemical and Metabolic Parameters Improvements in Diarrhea Severity and Nutritional Status THE WOODLANDS, Texas, May 04, 2018 (GLOBE NEWSWIRE) -- [...]
Intra-Cellular Therapies Announces Presentations on Lumateperone at Two Upcoming Medical Conferences
04/05/2018
NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced [...]
Avinger to Announce First Quarter 2018 Financial Results on May 14, 2018
04/05/2018
REDWOOD CITY, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will release its financial [...]
TG Therapeutics, Inc. to Host Conference Call on First Quarter 2018 Financial Results and Business Update
04/05/2018
Investor Conference Call to be held Tuesday, May 8, 2018 at 8:30am ET NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today announced that a conference call will be held on Tuesday, May [...]
Flexion Therapeutics Announces ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Recommended for Unique J Code by CMS
04/05/2018
BURLINGTON, Mass., May 04, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced the Centers for Medicare and Medicaid Services (CMS) has included ZILRETTA (triamcinolone acetonide extended [...]
Achaogen Reports First Quarter 2018 Financial Results and Provides Corporate Update
04/05/2018
-- FDA Advisory Committee voted in favor of plazomicin for treatment of adults with complicated urinary tract infections -- -- Conference call today at 8:30 a.m. Eastern Time -- SOUTH SAN FRANCISCO, Calif., May 04, 2018 [...]

Pages